Rutgers University

Cepheid, FIND, Rutgers collaborate on Xpert MTB/RIF test

Wednesday, October 29, 2014

Cepheid, a Sunnyvale, Calif.-based molecular diagnostics company, FIND, a Switzerland-based international nonprofit organization and Rutgers New Jersey Medical School are collaborating to develop Xpert MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis (TB) with increased sensitivity to aid in detection of patients with smear-negative TB, which often is associated with HIV co-infection. The collaboration also is receiving additional support from the National Institute of Allergy and Infectious Diseases at the NIH.

[Read More]

C-TASC Plans to Double Staff in ‘09

Friday, February 13, 2009

Clinical Trials and Surveys Corp (C-TASC), a clinical trials solutions company, hired three new biostatisticians and plans to double its staff in the next year. The company, which currently employs 35 people, plans to increase to 60 employees by February 2010 in order to keep up with increased demand for its clinical trial services and technologies.

[Read More]